Develops and commercializes immunotherapeutics for the treatment of cancer
Company profile
Ticker
MBVX
Exchange
Website
CEO
John David Hansen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Telik Inc
SEC CIK
Corporate docs
IRS number
930987903
MBVX stock data
Latest filings (excl ownership)
RW
Registration withdrawal request
19 Sep 19
SEC STAFF
SEC staff action: Order
22 Apr 19
SEC STAFF
SEC staff action: Order
22 Apr 19
SEC STAFF
SEC staff action: Order
22 Apr 19
SEC STAFF
SEC staff action: Order
22 Apr 19
15-12G
Securities registration termination
29 Mar 19
8-K
Bankruptcy or Receivership
25 Mar 19
8-K
MabVax Therapeutics and Oncotelic Enter into Merger Discussions
4 Jan 19
Latest ownership filings
SC 13G/A
Mabvax Therapeutics Holdings, Inc.
9 May 19
SC 13G
Mabvax Therapeutics Holdings, Inc.
6 Aug 18
SC 13D/A
Mabvax Therapeutics Holdings, Inc.
25 Jul 18
4/A
PAUL V MAIER
4 Apr 18
4/A
Kenneth M Cohen
4 Apr 18
4
Kenneth M Cohen
3 Apr 18
4
PAUL V MAIER
3 Apr 18
4
PAUL W MAFFUID
3 Apr 18
4
GREGORY P HANSON
3 Apr 18
4
JOHN DAVID HANSEN
3 Apr 18
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|